Cedars-Sinai investigators have discovered that large oncosomes—fluid-filled sacs released into the bloodstream by aggressive ...

The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has transformed life sciences, driving discoveries across immunology, oncology, and ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

This article makes a valuable contribution to the field by uncovering a molecular mechanism for miRNA intracellular retention, mediated by the interaction of PCBP2, SYNCRIP, and specific miRNA motifs.

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Ranjan Narula and Shakti Priyan Nair of RNA, Technology and IP Attorneys examine how Indian law and recent court rulings have ...